Donate
Close

About Us

Together, we can advance innovation, expand access to care and empower people to live well.

About the Foundation

Our Board

Foundation Team

Contact Us

Photo of Riggs BUMC ED exterior

Cancer care

Propel advances in cancer research and treatment, bringing hope and healing to patients.

Capital & technology

Invest in the future of healthcare by helping expand and modernize our North Texas facilities.

Community health

Expand access to compassionate healthcare for underserved individuals and families.

Graduate medical education

Shape the future of medicine by helping train the next generation of physicians.

In your region

Make a direct impact on Baylor Scott & White hospitals and patients in your community.

Patient programs

Help enhance patient well-being through innovative, patient-centered programs.

Research

Help drive discoveries and improve patient outcomes by supporting accessible research and clinical trials.

Transplant

Support life-changing care for transplant patients and their families.

See all areas to support

Donate online

Your gift can make an immediate difference in the lives of those we serve.

Grateful Giving

Patients and loved ones can show appreciation for the caregivers who made a difference during their healthcare experience.

Make a planned gift

Learn about the multiple ways to make a planned gift and create a lasting legacy.

Giving societies

Giving societies honor donors for their generosity in empowering people to live well.

See all ways to give
See all the ways to get involved

Celebrating Women

Help us advance the fight against breast cancer through Celebrating Women.

Grand Rounds

Support graduate medical education at Baylor Scott & White by participating in the Ground Rounds golf tournament.

Grand Rounds Golf Tournament logo

The Compass

Read the latest issue of The Compass, a quarterly newsletter from the Baylor Scott & White Dallas Foundation.

Research

  • Research

    March 17, 2025
    Areas to support in research Baylor Scott & White Research Institute – By the numbers BSWRI provides the critical infrastructure and operational resources needed to both safely and effectively conduct research across a broad range of specialty areas. Featured stories Learn how generous donors are helping drive medical breakthroughs by funding innovative studies in early […]
    Learn More Research
  • Breast Cancer TRIM Trial

    Breast Cancer TRIM Trial

    March 8, 2025
    Addressing obesity and breast cancer recurrence  Breast cancer remains the second-leading cause of cancer-related death among women in the United States. While early detection significantly improves survival rates, the ultimate goal is prevention.   Research has established a strong link between obesity and breast cancer recurrence, highlighting an urgent need for new strategies to reduce risk […]
    Learn More Breast Cancer TRIM Trial
  • Photograph of man and woman. Woman with bald head.

    Texas Immuno-oncology Biorepository

    January 21, 2025
    Unlocking the future of cancer treatment Less than 10% of adults with cancer participate in clinical trials, yet much of our research is based on findings from this small subset of patients—patients who are often younger, healthier, and not fully representative of the broader population affected by cancer. As a result, critical gaps remain in […]
    Learn More Texas Immuno-oncology Biorepository

  • Boon Family celebrates milestone in support of cancer research at Baylor Scott & White Health

    January 21, 2025
    For nearly two decades, the Boon family of Ennis has been dedicated to the fight against cancer. When they teed up for their 19th annual Cancer Benefit Golf Tournament in September, it was another opportunity to honor the memory of the late E.K. Boon and transform their grief into a quest of hope for so […]
    Learn More Boon Family celebrates milestone in support of cancer research at Baylor Scott & White Health
  • Multi-Cancer Early Detection Program

    Multi-Cancer Early Detection Program

    September 1, 2024
    With an aim of intercepting cancers in Texans earlier, the program includes approximately 50,000 MCED tests being administered to BSW patients across North Texas.
    Learn More Multi-Cancer Early Detection Program
  • headshot of Dr. Joyce O'Shaughnessy

    Intercepting breast cancer recurrence – Dr. Joyce O’Shaughnessy

    September 1, 2024
    A groundbreaking trial: New weight-loss drugs can help keep pounds away. Can they also help keep cancer at bay? Medications such as Wegovy® and Zepbound® have revolutionized the management of being overweight or obese. Researchers are now exploring these drugs’ potential benefits for a range of other conditions—possibly even to help prevent a recurrence of […]
    Learn More Intercepting breast cancer recurrence – Dr. Joyce O’Shaughnessy
  • Fighting cancer is in his blood—and ours

    Fighting cancer is in his blood—and ours

    June 1, 2024
    Baylor Scott & White Health chief of oncology demonstrates that immunotherapy combined with chemotherapy and radiation prior to surgical resection of a tumor, is safe while also demonstrating how to track tumor responses utilizing a novel blood test. Dr. Ronan Kelly · Chief of oncology for Baylor Scott & White Health in North Texas Understanding […]
    Learn More Fighting cancer is in his blood—and ours
  • Photo illustration with Cindy Marshall, MD

    New hope for Alzheimer’s patients

    September 1, 2023
    BSW AT&T Memory Center director Cindy Marshall, MD, answers questions about new FDA drug approval.
    Learn More New hope for Alzheimer’s patients
  • Texas Immuno-Oncology Biorepository launches inaugural research study

    Texas Immuno-Oncology Biorepository launches inaugural research study

    March 1, 2023
    Much of our current information about how to treat cancer comes from clinical trials; however, there are limits to what we can learn from trials alone. Ronan Kelly, MD, chief of oncology at Baylor Scott & White Charles A. Sammons Cancer Center and the W.W. Caruth, Jr. Chair in Immunology at Baylor University Medical Center, […]
    Learn More Texas Immuno-Oncology Biorepository launches inaugural research study

  • Esophageal cancer breakthrough gets FDA approval

    June 1, 2021
    Dr. Ronan Kelly authors study released in The New England Journal of Medicine on a global phase III clinical trial at 170 sites including Baylor University Medical Center in Dallas. The results of a study published in April in The New England Journal of Medicine (NEJM) found that the immunotherapy drug nivolumab (Opdivo®), if used […]
    Learn More Esophageal cancer breakthrough gets FDA approval